Predict your next investment

Evogen company logo
HEALTHCARE | Drug Development
evogen.com

See what CB Insights has to offer

Total Raised

$6.39M

Investors Count

4

Deal Terms

3

Evogen Funding, Evogen Valuation & Evogen Revenue

4 Fundings

Evogen's latest funding round was a Unattributed for $0.85M on February 19, 2014.

Evogen's valuation in November 2008 was $13.06M.

Evogen's latest post-money valuation is from November 2008.

Sign up for a free trial to see Evogen's valuations in April 2002 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

2/19/2014

Unattributed

$0.85M

Undisclosed Investors

1

1/26/2010

Debt

$99M

0

11/12/2008

Series B

$99M

$13.06M

0

4/8/2002

Series A

$99M

$99M

0

Date

2/19/2014

1/26/2010

11/12/2008

4/8/2002

Round

Unattributed

Debt

Series B

Series A

Amount

$0.85M

$99M

$99M

$99M

Investors

Undisclosed Investors

Valuation

$13.06M

$99M

Revenue

Sources

1

0

0

0

Evogen Deal Terms

3 Deal Terms

Evogen's deal structure is available for 3 funding rounds, including their Unattributed from February 19, 2014.

Round

Unattributed

Series B

Series A

Funding Date

$99M

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

$99M

Shares Authorized

Issuance Price

$99M

Dividend Rate

$99M

Liquidation Preferences

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

General Voting

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Unattributed

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

Evogen Investors

4 Investors

Evogen has 4 investors. L Capital Partners invested in Evogen's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/12/2008

11/12/2008

1
Series B

Venture Capital

New York

00/00/0000

00/00/0000

MRIGlobal

Subscribe to see more

Other

Missouri

00/00/0000

00/00/0000

MRI Ventures

Subscribe to see more

Venture Capital

00/00/0000

00/00/0000

Shalom Management

Subscribe to see more

Corporation

Israel

First funding

11/12/2008

00/00/0000

00/00/0000

00/00/0000

Last Funding

11/12/2008

00/00/0000

00/00/0000

00/00/0000

Investor

MRIGlobal

MRI Ventures

Shalom Management

Rounds

1
Series B

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Other

Venture Capital

Corporation

Location

New York

Missouri

Israel

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.